FDA OKs expanded use of Abbott's Absolute Pro stent

02/27/2012 | MassDevice.com (Boston)

The FDA has granted Abbott expanded premarket approval for use of its Absolute Pro stent in treating patients with narrowed iliac arteries. The catheter-delivered device, which has been on the U.S. market since 2008 as a biliary stent, is also being marketed in more than 80 other countries.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
European Sales Manager
SentreHEART, Inc.
Germany, Benelux, UK
REG AFFAIRS PROJ MGR - 1400000A7F
Abbott
San Jose, CA
SPECIALIST II SYSTEMS INTEGRATION - 140000033P
Abbott
Dallas, TX
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD